http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb0daa7cfb29e2c7775ce4f9cc44f3fc
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Psyrri |
| name | Amanda Psyrri |
| given-name | Amanda |
| organization-name | 8Second Department of Internal Medicine, Section of Medical Oncology, “Attikon” University Hospital, University of Athens, Athens, Greece. From the Department of Medicine, Section of Medical Oncology, Attikon University Hospital, Athens, Greece; Department of Medicine, University of Chicago School of Medicine and Biological Sciences, Chicago, IL; Division of Medical Oncology, University of Colorado School of Medicine, Denver, CO. Florentia Fostira, National Center for Scientific Research “Demokritos”; George Koutsodontis, Elena Vagia, Panagiota Economopoulou, Ioannis Kotsantis, and Amanda Psyrri, National and Kapodistrian University of Athens; Dimitra Rontogianni, Evangelismos Hospital, Athens, Greece; Clarence Sasaki, Yale University School of Medicine, New Haven, CT; and Christos Perisanidis, Medical University of Vienna, Vienna, Austria. 3Oncology Unit, 2nd Department of Internal Medicine-Propaedeutic, Attikon University Hospital, Haidari, Greece. Authors' Affiliations: 1Second Department of Internal Medicine, Propaedeutic, University of Athens, University General Hospital “Attikon”; 2Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Athens; Departments of 3Pathology and 4Hematology-Lymphomas, Evangelismos Hospital; 5Department of Medical Genetics, Athens University School of Medicine, Athens, Greece; and 6Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut; Authors' Affiliations: 1Second Department of Internal Medicine, Propaedeutic, University of Athens, University General Hospital “Attikon”; 2Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Athens; Departments of 3Pathology and 4Hematology-Lymphomas, Evangelismos Hospital; 5Department of Medical Genetics, Athens University School of Medicine, Athens, Greece; and 6Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut Second Propaedeutic Department of Medicine, Attikon University Hospital, 12462 Athens, Greece Attikon Hospital National and Kapodistrian University of Athens Athens Greece Attikon Hospital, University of Athens Medical School, Athens, Greece Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, Faculty of Medicine, National and Kapodistrian University of Athens School of Medicine, Athens, Greece Section of Medical Oncology, Department of Internal Medicine Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens Athens Greece 3Medical Oncology, Authors' Affiliations: 1Yale University School of Medicine, New Haven, Connecticut; 2Dana-Farber Cancer Institute, Boston, Massachusetts; 3Fox Chase Cancer Center, Philadelphia, Pennsylvania; 4Landmark Medical Center, Woonsocket, Rhode Island; 5Johns Hopkins University, Baltimore, Maryland; and 6Aristotle University of Thessaloniki, Thessaloniki, Greece 2Department of Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. Division of Oncology, 2nd Department of Internal Medicine Attikon University Hospital Athens Greece Department of Internal Medicine, Section of Medical Oncology, School of Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece Attikon University Hospital, Athens, Greece Department of Internal Medicine Section of Medical Oncology Attikon University Hospital National and Kapodistrian University of Athens School of Medicine Athens Greece Second Department of Internal Medicine, Oncology Section, University of Athens, “Attikon” University Hospital, Athens, Greece 1Medical Oncology and Departments of From the Departments of Medical Oncology, Otolaryngology, Therapeutic Radiology, Pathology, and Comparative Anatomy, Yale University School of Medicine, New Haven, CT 1Section of Medical Oncology and Authors' Affiliations: Departments of 1Internal Medicine, Section of Medical Oncology, and 2Surgery, Section of Otolaryngology, Yale University School of Medicine, New Haven, Connecticut; and 3Medical School, Athens University, Athens, Greece; Authors' Affiliations: Departments of 1Internal Medicine, Section of Medical Oncology, and 2Surgery, Section of Otolaryngology, Yale University School of Medicine, New Haven, Connecticut; and 3Medical School, Athens University, Athens, Greece Department of Internal Medicine, Section of Medical Oncology, National & Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece Authors' Affiliations: 1Gynecologic Medical Oncology Service, Department of Medicine, and 2Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York; 3Department of Medicine, Arizona Cancer Center, Scottsdale, Arizona; 4Department of Medicine, Yale University School of Medicine, New Haven, Connecticut; and 5Regeneron Pharmaceuticals Inc., Tarrytown, New York 1st Department of Cardiology, 'Hippokration' Hospital, University of Athens Medical School, Athens, Greece Department of Internal Medicine, National Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece 7Medical Sciences, Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; and Department of Medical Oncology Yale University School of Medicine New Haven CT National Kapodistrian University of Athens, Attikon Hospital, Athens, Greece National Kapodistrian University of Athens, Athens, Greece Second Department of Internal Medicine, Section of Medical Oncology, National & Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece Authors' Affiliations: Departments of 1Internal Medicine (Medical Oncology), 2Surgery (Otolaryngology), and 3Pathology, Yale University School of Medicine, New Haven, Connecticut; 4Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Departments of 5Medical Oncology and 6Pathology, Papageorgiou Hospital Aristotle University of Thessaloniki, Thessaloniki, and 7Second Department of Internal Medicine, Propaedeutic, Oncology Section, University of Athens, University Hospital "Attikon", Athens, Greece; Authors' Affiliations: Departments of 1Internal Medicine (Medical Oncology), 2Surgery (Otolaryngology), and 3Pathology, Yale University School of Medicine, New Haven, Connecticut; 4Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Departments of 5Medical Oncology and 6Pathology, Papageorgiou Hospital Aristotle University of Thessaloniki, Thessaloniki, and 7Second Department of Internal Medicine, Propaedeutic, Oncology Section, University of Athens, University Hospital "Attikon", Athens, Greece From the Second Department of Internal Medicine, Attikon Hospital University of Athens, Athens, Greece; Department of Radiation Oncology, Lausanne University Medical Center, Lausanne, Switzerland. 5Attikon University Hospital, Athens, Greece. Department of Internal Medicine, Section of Medical Oncology Attikon University Hospital Athens Greece 4Internal Medicine, Yale University School of Medicine, New Haven, Connecticut Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, Faculty of Medicine, National and Kapodistrian University of Athens School of Medicine, 12462 Athens, Greece Division of Oncology, Second Department of Internal Medicine, Attikon University Hospital, Athens, Greece Oncology Unit 2nd Department of Internal Medicine‐Propaedeutic Attikon University Hospital Haidari Greece 1Medical Oncology, Departments of Oncology Unit, Second Department of Internal Medicine, Attikon University Hospital, Haidari, Greece Division of Oncology, Second Department of Internal Medicine Attikon University Hospital Athens Greece Division of Oncology, Second Department of Internal Medicine, Attikon University Hospital, Athens, Greece. Oncology Unit, 2nd Department of Internal Medicine—Propaedeutic, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece Yale University, USA Attikon Hospital, National Kapodistrian University of Athens, Athens, Greece Department of Internal Medicine, Section of Medical Oncology, National and Kapodistrian University of Athens, Attikon University Hospital, 12462 Athens, Greece Head and Neck Oncology Unit, Yale University School of Medicine, New Haven, CT 06520, USA. diamando.psyrri@yale.edu Hellenic Society of Medical Oncology, 11475 Athens, Greece Medical Oncology Unit, Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece Section of Medical Oncology, Second Department of Internal Medicine, General University Hospital “Attikon”, University of Athens, Athens, Greece 2nd Department of Internal Medicine-Propaedeutic, University General Hospital “Attikon”, School of Medicine, National and Kapodistrian University of Athens, 12464 Athens, Greece Authors' Affiliations: Departments of 1Internal Medicine (Medical Oncology), 2Surgery (Otolaryngology), and 3Pathology, Yale University School of Medicine, New Haven, Connecticut; Departments of 4Pathology and 5Otolaryngology, University of Pittsburgh, Pittsburgh, Pennsylvania; 6Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; 7Laboratory of Biostatistics, University of Athens, Athens, Greece; and Departments of 8Medical Oncology and 9Pathology, Papageorgiou Hospital Aristotle University of Thessaloniki, Thessaloniki, Greece; Authors' Affiliations: Departments of 1Internal Medicine (Medical Oncology), 2Surgery (Otolaryngology), and 3Pathology, Yale University School of Medicine, New Haven, Connecticut; Departments of 4Pathology and 5Otolaryngology, University of Pittsburgh, Pittsburgh, Pennsylvania; 6Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; 7Laboratory of Biostatistics, University of Athens, Athens, Greece; and Departments of 8Medical Oncology and 9Pathology, Papageorgiou Hospital Aristotle University of Thessaloniki, Thessaloniki, Greece |
Incoming Links
Total number of triples: 253.